Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
NCT06120244
Healthy
Hamilton, Montana, United States
View Trial DetailsNCT Number: NCT07838402
The goal of this observational study is to evaluate a commercially available smart sock for heart rate monitoring in hospitalized newborn infants without known heart disease. The study aims to determine whether the smart sock provides heart rate information comparable to that obtained from the standard patient monitor used in routine neonatal care.
The main questions this study aims to answer are:
* Does the smart sock provide heart rate measurements comparable to those obtained from the standard patient monitor? * Does the smart sock provide comparable information on clinically relevant rhythm abnormalities? * How do parents and healthcare professionals perceive the usability and safety of the smart sock? Participants will wear the smart sock while undergoing routine monitoring on the neonatal ward. Heart rate and rhythm data from the smart sock will be compared with data from the standard patient monitor. Parents and healthcare professionals will provide feedback on the usability and perceived safety of the device.
Trial opening soon.
Get Notified0 day–28 day
All sexes
Observational
Commercially available wearable monitoring devices for infants are increasingly used, but evidence on their performance in hospitalized newborns is limited. This study evaluates the accuracy and usability of the Owlet Dream Sock™ in hospitalized newborn infants. Heart rate and rhythm data obtained from the smart sock will be compared with data from the standard patient monitor used in routine neonatal care. In addition, parents and healthcare professionals will evaluate the usability and perceived safety of the device.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From initiation of smart sock monitoring through completion of the 12-16-hour monitoring period
Heart rate data obtained from the smart sock will be compared with simultaneous heart rate data obtained from the standard patient monitor used in routine neonatal care.
Time frame: From initiation of smart sock monitoring through completion of the 12-16-hour monitoring period
Rhythm abnormalities and rhythm-related alarms identified by the standard patient monitor will be reviewed and compared with data obtained from the smart sock to assess the ability of the smart sock to detect clinically significant rhythm abnormalities lasting >3 minutes.
Time frame: Immediately after completion of the 12-16-hour smart sock monitoring period
Usability of the smart sock as assessed by parents and healthcare professionals using a questionnaire.
Contact information is provided by the study sponsor or research team.
Kirsi Ylä-Tuuhonen, MD
CONTACT
Minna Mecklin, MD, PhD
CONTACT
Tampere University Hospital
Other
Evaluation of a Smart Sock for Heart Rate Monitoring in Hospitalized Newborn Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06120244
Healthy
Hamilton, Montana, United States
View Trial DetailsNCT07837648
Healthy
View Trial DetailsNCT07833865
Autoimmune Diseases, Diabetes Mellitus
View Trial DetailsNCT07830862
Healthy
Guelph, Ontario, Canada
View Trial Details